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Acetylcholine is a ubiquitous cortical neuro-
modulator implicated in cognition. In order to
understand the potential for acetylcholine to
play a role in visual attention, we studied nico-
tinic acetylcholine receptor (nAChR) localiza-
tion and function in area V1 of the macaque.
We found nAChRs presynaptically at thalamic
synapses onto excitatory, but not inhibitory,
neurons in the primary thalamorecipient layer
4c. Furthermore, consistent with the release
enhancement suggested by this localization,
we discovered that nicotine increases respon-
siveness and lowers contrast threshold in layer
4c neurons. We also found that nAChRs are ex-
pressed by GABAergic interneurons in V1 but
rarely by pyramidal neurons, and that nicotine
suppresses visual responses outside layer 4c.
All sensory systems incorporate gain control
mechanisms, or processes which dynamically
alter input/output relationships. We demon-
strate that at the site of thalamic input to visual
cortex, the effect of this nAChR-mediated gain
is an enhancement of the detection of visual
stimuli.
INTRODUCTION
As a central nervous system neuromodulator, acetylcho-
line (ACh) is involved in processes underlying the sleep/
wake cycle and arousal (Jasper and Tessier, 1971; Jime-
nez-Capdeville and Dykes, 1996; Vazquez and Bagh-
doyan, 2001), reward and addiction (Maskos et al.,
2005), attention (Sarter et al., 2005), and learning and
memory (Everitt and Robbins, 1997; Hasselmo and
McGaughy, 2004; Rezvani and Levin, 2001), and in a num-
ber of neuropathologies including Alzheimer’s disease
(Gallagher and Colombo, 1995). The rewarding and addic-
tive nature of nicotine is mediated by cholinergic action in
subcortical structures (Maskos et al., 2005), and learning
and memory functions of ACh are subserved by choliner-
gic projections to the hippocampal formation (Everitt and
Robbins, 1997) with a lesser role for the neocortical cholin-
ergic projection (Hasselmo and McGaughy, 2004). How-
ever, based on work in rodents, the cholinergic projectionNefrom the basal forebrain area (BFA) to neocortex is
believed to be primarily involved in processes that underlie
arousal and attentional modulation (Everitt and Rob-
bins, 1997; Hasselmo and McGaughy, 2004; Sarter
et al., 2005).
In addition to (or perhaps as part of) its role in higher
functions, cholinergic neuromodulation in the neocortex
is also involved in normal sensory processing; after lesions
of the BFA, many visual cortical neurons no longer re-
spond to visual stimuli (Sato et al., 1987a). The role of
ACh in the processing of sensory stimuli has been exten-
sively studied, particularly in the visual cortex (Muller and
Singer, 1989; Murphy and Sillito, 1991; Roberts et al.,
2005; Sato et al., 1987a, 1987b; Sillito and Kemp, 1983;
Zinke et al., 2006), but the reported effects of ACh are
diverse and in some cases contradictory. In order to clarify
the role of ACh in the sensory cortices, we pursued a de-
tailed anatomical and pharmacological dissection of neo-
cortical cholinergic neuromodulation, beginning with the
role of nicotinic ACh receptors (nAChRs) in a well-studied
cortical model system, the primary visual cortex (V1) of the
macaque monkey.
In macaques, V1 receives its cholinergic innervation
from the nucleus basalis (Pearson et al., 1983). In the neo-
cortex, ACh is usually released from varicosities that are
not apposed to a synaptic specialization (Aoki and Kabak,
1992; Beaulieu and Somogyi, 1991; but see Turrini et al.,
2001). This mode of release, known as volume transmis-
sion, means that receptor subtype and localization criti-
cally determine signaling specificity. There are multiple
ionotropic and metabotropic subclasses of AChRs (Brown
et al., 1997; Metherate, 2004), and in V1, both muscarinic
AChRs (mAChRs) (metabotropic, primarily the m1 and m2
subtypes; Tigges et al., 1997) and nicotinic (ionotropic)
AChRs (Han et al., 2000) are expressed at significant
levels.
Although previous anatomical studies exist suggesting
a presynaptic localization for nAChRs on thalamic axons
arriving in primary sensory areas (Parkinson et al., 1988),
and although in vitro studies also indicate a nicotinic mod-
ulation of ascending pathways into cortex (Gil et al., 1997;
Hsieh et al., 2000; Kimura et al., 1999), the precise type
and localization of the nAChRs responsible for these
effects is still not known. We conducted a tract-tracing
and immunocytochemical electron microscopic (immuno-
EM) study to localize mAChRs and nAChRs within layer
4c, the principal thalamic recipient zone in macaque V1.
To provide a more complete description of the cholinergic
modulation of V1, we also used dual immunofluorescenceuron 56, 701–713, November 21, 2007 ª2007 Elsevier Inc. 701
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Gain Modulation by Nicotine in Macaque V1Figure 1. Localization of AChRs by EM-Immunocytochemistry
(A) Labeling for the b2-nAChR subunit by silver-intensified gold (upper inset; scale bar, 10 mm) and anterogradely traced LGN terminals by ABC-DAB
(middle inset; scale bar, 20 mm). (B) An EM image of a tracer-labeled terminal (t+) synapsing onto a spine (sp; note the spine apparatus, arrow), show-
ing that tract-tracing allows identification of thalamic terminals in single planes of section in which the presynaptic element is otherwise difficult to
distinguish. Silver particles (arrowheads) indicate presynaptic b2-nAChRs. Scale bar, 200 nm. (C) The quantification of b2 labeling at layer 4c synap-
ses (x axis: sp, spine; sh, shaft; +, labeled terminals; , unlabeled terminals). 76% of thalamic synapses onto spines in layer 4c are presynaptically
immunoreactive for b2 subunits. No thalamic synapses onto dendrites are b2-nAChR-ir. Layer 4c thalamic synapses are immunonegative for m1 (D)
and m2 (E) muscarinic receptors.to determine the extent to which AChRs, both nicotinic
(this study) and muscarinic (Disney et al., 2006), are
expressed by inhibitory versus excitatory neurons. Finally,
to confirm predictions made by these anatomical data,
we conducted in vivo experiments that combined ionto-
phoresis of cholinergic agonists with extracellular record-
ings of the functional properties of neurons in all layers
of V1.
Here we show that presynaptic high-affinity nAChRs are
found on afferent fibers arriving from the principal visual
thalamic relay, the lateral geniculate nucleus (LGN), in
layer 4c of V1 in the macaque monkey. We also demon-
strate that iontophoretic application of nicotine enhances
the response gain (i.e., increases the spiking response to
a given stimulus contrast) of neurons in layer 4c of V1,
but not in other layers. These effects are dose dependent,
transient, and in most neurons not due to changes in
maintained discharge.
RESULTS
AChR Expression at Thalamocortical Synapses
in Layer 4c
First we determined the subcellular distribution of nAChRs
and mAChRs in V1 using tract-tracing and electron
microscopy (EM). We injected an anterograde tracer into
the primary visual thalamic relay, the LGN, of three ma-
caques in order to identify thalamic terminals in layer 4c
of V1 (Figures 1A and 1B). Thalamocortical (TC) synapses702 Neuron 56, 701–713, November 21, 2007 ª2007 Elsevier Incin layer 4c were identified and the AChR distribution (pre-
synaptic and postsynaptic) at synapses onto spines and
shafts was determined by EM. We compared tracer-pos-
itive (thalamic) synapses with tracer-negative (presumed
nonthalamic) excitatory (i.e., asymmetric, Figure 1B) syn-
apses and found b2 subunits (nAChR) expressed presyn-
aptically at 76% of thalamic synapses onto spines (Fig-
ure 1C, left bar; 29/38 synapses), but at 0% of thalamic
synapses onto dendritic shafts (Figure 1C, second bar
from left; 0/9 synapses). Because glutamatergic (i.e.,
spiny) neurons receive most of their excitatory synapses
at spines, while GABAergic (aspiny or sparsely spiny) neu-
rons receive excitatory synapses directly to the dendritic
shaft, this nAChR localization at synapses onto spines
and not shafts indicates a targeted modulation of the tha-
lamic input to cortical excitatory cells. In contrast to the
strong expression at thalamic synapses, nAChRs were
present at only 12% (29/242) of other excitatory synapses
onto shafts and spines in layer 4c (Figure 1C, right pair of
bars).
In contrast to their strong expression of nicotinic re-
ceptors, no thalamic axons or terminals expressed
membrane-associated m1AChRs (Figure 1D, left pair of
bars; 0/24), and only one thalamic terminal was immuno-
reactive for the m2AChR (Figure 1E, left pair of bars;
1/34). m2AChRs were, however, observed on nonterminal
membranes of 27% (6/22) of thalamic axons in the
lower half of layer 4c (4cb). No axon segments in upper
layer 4c (4ca) were m2 immunoreactive. Finally, a small.
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Gain Modulation by Nicotine in Macaque V1Figure 2. Expression of Nicotinic Receptors by V1 Interneurons
(A) Dual immunofluorescence from layer 3. The red channel (left) shows GABA immunoreactivity; the green channel (middle) shows b2-nAChR-
immunoreactivity. In the merged image (right), dual-labeling appears yellow. In every layer the proportion of b2-nAChR-ir somata that are also
GABA-ir exceeds 60% (B). By EM there is prominent b2-nAChR immunolabeling of putatively inhibitory dendrites—in (C), a layer 4cb shaft (d) receives
direct asymmetric synapses (black asterisks), suggesting that it is the dendrite of a GABAergic (aspiny) neuron. The dendrite is densely b2-nAChR
immunoreactive (black arrowheads). Also visible is an asymmetric synapse onto a spine (sp) that has presynaptic b2-nAChR immunoreactivity in
the terminal (t) cytoplasm. The empty space inside the terminal (s) is the tissue surface—data were collected very close to the tissue/EPON interface.
Scale bar, 200 nm. (D) Some b2-nAChR-ir neurons express the calcium-binding proteins (CBP) calbindin (CB) (left; 111 of 641 neurons, 17%) and
parvalbumin (PV) (right; 76 of 254 neurons, 30%). In contrast, very few b2-nAChR-ir neurons in any layer express calretinin (CR) (middle; 25 of 453
neurons, 6%). All error bars = SEM.population of nonthalamic excitatory synapses expressed
mAChRs (Figures 1D and 1E, right pair of bars; m1: 3/117,
m2: 13/158). The predominant effect of ACh acting on tha-
lamic axons in layer 4c is thus expected to be a presynap-
tic, nAChR-mediated modulation of the thalamic input to
excitatory neurons.
nAChR Expression by Interneurons in Macaque V1
To further elucidate how ACh acts on the cortical circuit
(i.e., beyond the TC synapse) we compared b2-nAChR
subunit expression between excitatory and inhibitory
neurons. We have shown previously that mAChRs are
strongly expressed by inhibitory neurons in macaque V1
(Disney et al., 2006). Inhibitory neurons can be identified
using antibodies directed at the neurotransmitter g-ami-
nobutyric acid (GABA)—the remaining neurons can be
presumed to be excitatory. We examined coexpression
of b2-nAChR subunits with GABA using dual-label immu-
nofluorescence microscopy and found that few V1 neu-
rons, whether excitatory or inhibitory, express b2 sub-
units. Of those that do, most are GABAergic (Figures 2A
and 2B). Across layers, 75% (644/861) of b2-nAChR-
immunoreactive (nAChR-ir) somata were GABA immuno-
reactive. However, this represented only 25% (644/2577)
of the GABAergic population. GABAergic neurons com-
prise 20% of all V1 neurons (Beaulieu et al., 1992).
Thus, only 7% of V1 neurons express b2-nAChR sub-Neuunits, of which >70% (i.e., 5% of the total V1 population)
are b2 subunit-expressing inhibitory neurons. This is qual-
itatively supported by the observation that dendrites
which, in the above EM study, expressed b2 subunits
received asymmetric synapses directly onto the dendritic
shaft (i.e., they were aspinous and putatively inhibitory;
Figure 2C).
Inhibitory neurons can be subdivided based upon cal-
cium-binding protein (CBP) expression, a classification
scheme that may predict a neuron’s spiking properties
(Kawaguchi and Kubota, 1993; Toledo-Rodriguez et al.,
2004). The three CBPs, parvalbumin (PV), calbindin
D-28k (CB), and calretinin (CR) are expressed in macaque
V1 (DeFelipe et al., 1999; Meskenaite, 1997; Van Breder-
ode et al., 1990). We examined the coexpression of the
b2-nAChR subunit with each of these markers (Figure 2D)
and found that most b2-nAChR-ir neurons in macaque V1
express PV (which in rodents is a marker for the fast-spik-
ing [FS] neuronal phenotype; Kawaguchi and Kubota,
1993; Toledo-Rodriguez et al., 2004). b2 expression was
moderate (approximately one-third of cells) in the CB neu-
rons of layers 2, 3, 4b, 5, and 6, but very weak in CB neu-
rons within the thalamic recipient layers 4a and 4c. PV
neurons showed low to moderate b2 subunit expression
across all layers. It should be noted, however, that while
both PV and CB neurons express nicotinic receptors, PV
neurons represent 75% of GABAergic neurons in macaqueron 56, 701–713, November 21, 2007 ª2007 Elsevier Inc. 703
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Gain Modulation by Nicotine in Macaque V1Figure 3. The Effect of Nicotine on Visual
Gain in V1
(A) The average, across neurons, of the
summed contrast responses (area under the
contrast-response curve) obtained at the max-
imum applied iontophoretic current. Data are
normalized to the response obtained before
any nicotine was applied. Nicotine produces
an increase in gain in layer 4c but not in any
other layer (number of sites in parentheses
above each bar).
(B) The development of the nicotine effect in 4c
across repeats of contrast-response measure-
ment.
(C) Normalized contrast-response area was stationary in the absence of nicotine. Only data for sites enhanced by nicotine are shown in (C) (i.e., not all
4c sites as in [A] and [B]; see main text).
y axis, all graphs: normalized area. All error bars = SEM.V1 and greatly outnumber CB neurons, particularly in layers
4a–4c (Van Brederode et al., 1990). CR neurons rarely
expressed b2 subunits.
The Effect of Nicotine on V1 Responses In Vivo
Our fluorescence and EM data together show that b2 sub-
unit-containing nAChRs are expressed by most TC termi-
nals in layer 4c and by very few intrinsic V1 neurons. Addi-
tionally, mAChRs are not expressed by TC terminals.
Consequently, the dominant cholinergic effect in layer 4c
of V1 should be a nicotinic modulation of TC transmission.
nAChRs are ionotropic cation channels; they produce
a fast membrane depolarization which, at an axon termi-
nal, would increase the probability of vesicle release.
Thus, combining iontophoretically applied nicotine with
visual stimulation should result in elevated neuronal
responses in layer 4c. Altering the relationship between
stimulus contrast and spike rate in this way would repre-
sent a form of visual gain change.
A sensitive measure of visual gain used in humans and
macaques is responsiveness to contrast (see Figure S1
in the Supplemental Data available with this article online;
Carrasco et al., 2000; Ling and Carrasco, 2006; McAdams
and Reid, 2005; Reynolds et al., 2000; Williford and
Maunsell, 2006). We measured the extracellular spiking
response to optimized drifting grating stimuli (see Experi-
mental Procedures) of increasing luminance contrast at 72
sites across the layers of V1 with and without nicotine ap-
plication. In approaching these data, first we analyzed the
population response in each cortical layer using a non-
parametric (model-free) analysis. Second, we used a com-
mon parametric (model-based) analysis of the contrast-
response relationship to determine the nature of the gain
change. Gain was increased at 18 of 27 layer 4c sites by
the nonparametric analysis and at 13 of 27 sites by the
parametric analysis.
Nonparametric Analysis
To quantify the gain effect, we used a nonparametric mea-
sure, taking the average spike rate (across two to five
repeats, with one repeat being one sequence of 12 con-
trast steps spanning 2%–96%, with interleaved blanks)704 Neuron 56, 701–713, November 21, 2007 ª2007 Elsevier Inat each stimulus contrast and summing across all 12 con-
trasts tested. This measure is equivalent to the area under
the contrast curve and does not depend on fitting a model
function to the data. The area under the contrast-response
curve (or response area) at the maximum applied ionto-
phoretic current (usually 120 nA; range 40–160 nA) was
normalized to the area before nicotine ejection (baseline
response area) and the results averaged by layer. By this
analysis, nicotine strongly enhanced responses in layer
4c (Figure 3A) but not in other layers.
To identify significant effects we compared the response
area at the maximum applied iontophoretic current with
the response area of the immediately preceding control
(no drug) condition. If the mean area with nicotine was 3
standard deviations (SD) above (or below) the mean across
the control repeats, the site was deemed significantly en-
hanced (or suppressed). By this categorization, 22 of 72
sites (18 in 4c, 3 in unknown layers, 1 in layer 3) were en-
hanced and 7 sites (3 in layer 2/3, 3 in layer 5, 1 in an un-
known layer) were suppressed. The remaining units
showed no significant changes (43/72). Enhanced cells
did not differ from unaffected layer 4c cells on any
receptive field or baseline response property we measured
(simple/complex, breadth of orientation tuning, direction
selectivity, surround suppression). We included in our
baseline measures a metric that captures the mix-
ing of thalamic inputs carrying luminance (magnocellular
pathway) and color (parvocellular pathway) information
(Johnson et al., 2001). Based on a null response to an
isoluminant stimulus and on responsiveness to very-low-
contrast stimuli, 9 of the 18 enhanced layer 4c sites re-
flected a dominance of magnocellular (luminance) inputs.
The nicotine effect was observed in both the magnocellular
(4ca) and parvocellular (4cb) subdivisions of layer 4c and
was dynamic: there was a significant (p < 0.001; paired t
test) increase in the area under the contrast curve across
the first two repeats with a plateau after 48–96 s of nicotine
exposure (Figure 3B). With iontophoretic currents below
100 nA, the response area increased across all repeats,
suggesting that currents >100 nA may have released satu-
rating amounts of nicotine. Contrast-response area was
stationary before nicotine application (Figure 3C).c.
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current in the enhanced neurons and at 40 nA iontopho-
retic current in neurons that were suppressed. In both
groups the effect was monotonic with increasing cur-
rent, up to 120 nA (Figure 4A). Most neurons that were
enhanced at the maximum current level were also signifi-
cantly enhanced at lower current levels, and the popula-
tion shows enhancement at the lowest levels tested
(1–39 nA, usually 20 nA; Figure 4A). Neurons recovered
rapidly, returning to baseline early in the first recovery
run (i.e., <45 s) after each nicotine application (shown for
the enhanced group in Figure 4B).
Because our nicotine solution was at pH 3, control
experiments were run to eliminate the possibility that the
observed enhancement was a pH effect. At 38 sites (in-
cluding 12 enhanced sites), combined current/pH controls
were run using saline adjusted to pH 3. While there was
a very weak excitatory effect of this solution on some neu-
rons (it was suppressive in others), it could account for no
more than 10% of the magnitude of the nicotine effect
(Figure 5A). Enhanced neurons were not different from
other neurons in their responses to pH or high-ejection
currents (Figure 5B). Additionally, our preliminary data on
the effects of ACh (pH 5) and carbachol (pH 6.5) on con-
trast responses in layer 4c reveal a similar enhancement
with these closer-to-neutral pH solutions (Figure 5C).
Finally, in preliminary antagonist experiments, mecamyl-
amine (an nAChR antagonist) blocked the nicotine effect
at six of eight enhanced sites (Figures 5D and 5E).
Increased spike rates during nicotine application could
be due to changes in visually driven or spontaneous activ-
ity. To determine the level of spontaneous discharge, we
Figure 4. Nicotine EffectsWere Dose Responsive and Recov-
ered Rapidly
(A) The averaged, normalized response area as a function of ejection
current for enhanced, suppressed, and unaffected neurons.
(B) Nicotine iontophoresis was always followed by recovery runs in
which the contrast-response function was measured without ionto-
phoresis of any substance. These data come from the first recovery
run after nicotine was delivered. At enhanced sites, high ejection
currents often produced a recovery overshoot (below baseline), but
enhancement was still seen in subsequent nicotine runs. (Note: first
open square is labeled ‘‘recovery’’ because the order of delivery of
nicotine doses varied from neuron to neuron).
All error bars = SEM.Neusummed the spike rate across the blank (no stimulus)
periods that were interleaved between stimulus presenta-
tions. The difference in spike rate during blank stimuli
between the nicotine and baseline conditions (before
any drug was applied) was used to estimate the change
in spontaneous discharge due to the drug, adopting the
same mean ±3 SD criterion described above. Using this
measure, 8 of 22 enhanced sites showed significant
increases in background firing, and 1 showed suppres-
sion. For the eight sites with increased background firing,
we subtracted the summed spike rate across the blanks
from the spike rate across the stimulus presentations for
both conditions to determine the effect of nicotine on the
visually driven response alone. Effects on background
activity, assessed in this manner, accounted for the entire
nicotine enhancement in 2 (of 22) cases. Thus, 7 of 22
enhanced sites showed mixed background and driven
spike rate changes (6 with increased background, 1 sup-
pressed) and 13 of 22 showed a pure enhancement of
driven activity.
Parametric Analysis
Changes in visual gain, as measured by the contrast-
response function, are often assessed by a parametric
(i.e., model-based) analysis, which can give insights into
the mechanisms that underlie gain changes (e.g., Rey-
nolds et al., 2000; Williford and Maunsell, 2006). To allow
comparison with earlier studies, we fit the contrast re-
sponses with a model function that provides values for
the slope, asymptote (maximum response rate; Rmax),
half-maximum (contrast giving the half-maximum re-
sponse; c50) and y-offset (spontaneous activity; sFR) of
a hyperbolic ratio function (Naka-Rushton, see Experi-
mental Procedures and Figure S1) describing the relation-
ship between increasing contrast and spike rate. We then
performed 1000 bootstrapped fits on data from the
nicotine level that produced the maximum effect (see
Experimental Procedures) and the immediately preceding
no-drug control condition (Figure 6A) to obtain estimates
of the parameters in each condition. The distributions of
the parameter estimates from the nicotine and baseline
conditions were compared to determine statistical signif-
icance (Figures 6B and 6C).
The fit value for the Rmax parameter was significantly
increased at 10 sites, all in layer 4c (Figure 7A), indicating
a response (or activity) gain effect of nicotine (see Fig-
ure S1). A further three sites in 4c and five sites for
which histological confirmation of layer was unavailable
approached significance (p < 0.10). Nicotine did not alter
contrast gain; significant (p < 0.05) changes were very
rare in the c50 parameter (Figure 7B; 2 of 72 sites; 1 in
layer 2/3, the other in 4b). The sFR (3 of 72 sites; 2 in layer
4c, 1 in 2/3) and slope (1 layer 4c site) parameters were
also unchanged by nicotine in most cases. Ten of the thir-
teen layer 4c sites identified by bootstrap as showing in-
creases (p < 0.1) in Rmax were among those identified
as enhanced by the nonparametric analysis above.ron 56, 701–713, November 21, 2007 ª2007 Elsevier Inc. 705
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Gain Modulation by Nicotine in Macaque V1Figure 5. The Gain Enhancement in Layer 4c Is Not a pH Effect
Combined current and pH controls were run for 38 (of 72) neurons, including 12 (of 22) enhanced sites. A saline solution, adjusted to pH 3.0, was
ejected using the same range of currents as was used to eject nicotine. In this way the effects of pH and current are both examined. (A) For the
12 enhanced sites, the pH 3.0 saline was weakly excitatory (diamonds), but the magnitude of the effect was 10-fold smaller than that observed
for nicotine (squares). The peak normalized response areas (both obtained at 80 nA) were as follows: pH 3.0 saline = 1.096, nicotine = 2.020. At
very high ejection currents (>80 nA), the pH 3.0 solution was actually slightly suppressive. n = 8 for the 120–159 nA data point. In (B), it can be
seen that the effect of the pH 3.0 solution on normalized response area did not differ between enhanced (squares) and unaffected (diamonds) sites.
In addition, in preliminary experiments using the broad cholinergic agonists ACh (gray triangles; pH 5.0) and carbachol (circles; pH 6.5), we observed
a similar enhancement in layer 4c with nonacidic solutions (C). Our preliminary antagonist studies also show that the effect of nicotine is eliminated
following receptor blockade. (D) Data for an example cell in which mecamylamine was used as an nAChR antagonist. Fits were obtained for contrast-
response functions under baseline conditions (filled gray circles/solid lines) and during iontophoresis of nicotine (black circles/lines; 40 nA) or nicotine
(40 nA) plus mecamylamine (120 nA; open gray circles/dashed lines). The effect of nicotine was completely blocked by mecamylamine in this cell,
as it was for five other cells ([E]; effect was blocked in six of eight enhanced cells; data shown is the average across all eight cells tested with
mecamylamine).
Error bars = SEM for (A)–(C) and (E), SD in (D).Reliable Enhancement of Low-Contrast
Responses with Nicotine
A feature of the effect of nicotine that is not captured by
the above analyses is the emergence of reliable responses
to low-contrast stimuli, indicating a reduction in contrast
threshold. Figures 8A–8C show three example cells from
layer 4c (all significantly altered by nicotine by both para-
metric and nonparametric analysis). The contrast value at
which each cell’s driven rate reliably rises above back-
ground (i.e., when the error bar for that data point clears
the horizontal line representing the background firing
rate) is lower with nicotine for all three cells (as it is for
a fourth cell, shown in Figure 6A). This is representative706 Neuron 56, 701–713, November 21, 2007 ª2007 Elsevier Inof the effect of nicotine across the population of enhanced
cells and indicates that low-contrast detection is
improved with nicotine. Figures 8A–8C also illustrate that
this gain effect would best be described as a multiplicative
(as opposed to an additive) response gain for most cells,
supported by the lack of changes in the c50 or sFR param-
eters. A small number of cells showed evidence of an ad-
ditive activity gain or a mixed activity/response gain. In
Figure 8D, data for neurons showing a significant change
in Rmax (all in layer 4c) have been normalized, averaged,
and fit to show the population response to nicotine versus
control—the increased sensitivity and responsiveness are
clearly evident.c.
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Gain Modulation by Nicotine in Macaque V1Figure 6. Parametric Analysis: Single-
Cell Example
Spike responses were averaged and fit with
a Naka-Rushton function (see Experimental
Procedures). The parameters Rmax, c50, and
n are the maximum firing rate and the contrast
and slope at half-maximum, respectively; the
parameter sFR captures offset attributable to
background activity. (A) The fits obtained for
a representative cell from layer 4c. The nicotine
curve (black) is shifted to the left—indicating
increased sensitivity—and shows a higher
maximum response than baseline (gray). Error
bars = SD. A bootstrap analysis (1000 samples)
performed on data for this cell (see Experimen-
tal Procedures) shows that nicotine alters
Rmax (B), but not c50 (C).DISCUSSION
We have shown that in macaque V1, b2-nAChRs are found
presynaptically at TC synapses onto spines, but not at TC
synapses onto dendritic shafts. Furthermore, very few
neurons intrinsic to V1 express b2-nAChR subunits. Of
the V1 neurons that do express b2-nAChRs, most are
GABAergic neurons expressing either CB or PV. Consis-
tent with our anatomical data, we have also demonstrated
in vivo that nicotine reliably enhances the gain of
responses to visual stimuli in layer 4c, but not in other
layers. As a consequence, through enhanced TC trans-
mission, nicotine enhances detection of visual stimuli.
Nicotinic Modulation of TC Synapses
and Inhibition
Our anatomical data are consistent with and extend those
from previous studies. While there is no prior quantitative
data, it has been suggested previously that among the
neurons in the rodent cortex, high-affinity nAChRs are
selectively expressed by inhibitory interneurons (Methe-
rate, 2004). We show that in layers 2–6 of macaque V1,
75% of the cells expressing nAChRs also express
GABA. This would predict an excitatory effect of nicotineNeuon some inhibitory neurons, particularly those expressing
CB or PV. In rodents, inhibitory interneurons are often sub-
divided into two classes, FS and non-FS neurons. FS cells
express PV, and some non-FS cells express CB (Kawagu-
chi and Kubota, 1993). Non-FS interneurons recorded in
vitro have been shown to be exited by nicotine (Christophe
et al., 2002; Gulledge et al., 2007; Xiang et al., 1998).
These data are consistent with our observation that
CB-ir neurons express b2-nAChRs. We also found that a
distinct subset of PV-ir neurons expresses b2-nAChRs.
This is interesting, given previous studies of FS (PV-ir) neu-
rons in rodents, which report either no cholinergic modu-
lation (Gulledge et al., 2007; Kawaguchi, 1997) or a solely
muscarinic modulation (Xiang et al., 1998). It may be that
FS cells as a group respond heterogeneously to choliner-
gic agonists, but also that an as yet unidentified, anatom-
ically specified subgroup of FS cells express b2-nAChRs.
It will be a goal of future research to determine the firing
pattern and neuronal geometry of our dually labeled
b2-nAChR/PV interneurons.
While the localization of high-affinity nAChRs to tha-
lamic afferents in cortical input layers has been suggested
previously based on receptor autoradiography combined
with thalamic lesions (Lavine et al., 1997; ParkinsonFigure 7. Population Data on Rmax
Changes from Parametric Analysis
(A) A bootstrap analysis on the Rmax parame-
ter of fits from the baseline (x axis) and nicotine
(y axis) conditions shows that Rmax is elevated
by nicotine at most layer 4c sites (black cir-
cles). In contrast, the data from other layers
(gray circles) is clustered around the unity
line. Nicotine did not alter c50 in any layer (B).
Data from 15 recording sites for which histo-
logical reconstruction was not possible is not
shown. None of the omitted sites showed a
significant change in Rmax or c50.ron 56, 701–713, November 21, 2007 ª2007 Elsevier Inc. 707
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Thresholds for Neurons in Layer 4c
Fits are shown for three cells in layer 4c (A–C)
and for the population of cells that showed
Rmax changes (D) with nicotine data in black
and baseline data in gray. Spontaneous firing
rates in (A)–(C) are indicated by the filled
squares at the far left of each graph (‘‘Sp’’ on
the x axis) and by the dashed lines extending
from the squares. For all three cells, the con-
trast at which the nicotine response reliably
rises above the threshold set by the back-
ground activity (black arrows, set to the first
point for which the error bars clear the dashed
line) is lower than the corresponding threshold
contrast under baseline conditions. Error bars =
SD. In (D), data from the neurons that showed
changes in Rmax (p < 0.1) have been normal-
ized to the maximum firing rate obtained under
baseline conditions, averaged, and fit. Sponta-
neous activity was not significantly altered in
these neurons and the normalized spontane-
ous rate has thus been averaged across both
conditions—the value shown is this mean plus
3 SD (dashed line). The threshold contrast de-
fined by this level of background activity is
lower (2% contrast) with nicotine than under
baseline conditions (4%). Closer inspection
reveals that this is the case regardless of the
chosen value for threshold contrast.et al., 1988), these studies could not resolve the localiza-
tion or numerosity of layer 4 nAChRs. Our EM study
directly verifies the localization of b2-nAChRs on afferent
terminals in monkeys. Importantly, by using EM we were
also able to show that b2-nAChRs are found at the tha-
lamic input onto spines, but not onto dendritic shafts. In-
hibitory neurons are sparsely spiny or aspiny and receive
excitatory inputs directly to the dendritic shaft. Thus, the
population of TC synapses onto dendritic shafts observed
in this study probably contains within it (if it is not entirely
comprised of) thalamic input to inhibitory neurons. This
selective expression indicates the potential for nicotine
to strengthen the ascending drive to excitatory over inhib-
itory thalamorecipient neurons.
We also found that terminal segments of thalamic axons
did not express mAChRs. We did, however, observe a
small population of TC axons (i.e., nonterminal segments)
in layer 4cb expressing m2 AChRs. In this subdivision of
layer 4c, the effect of cholinergic modulation on TC trans-
mission may not be completely captured due to our use of
a selective nicotinic agonist. The presence of m2 AChRs in
layer 4cb has been reported previously (Mrzljak et al.,
1996), in an EM study that did not employ a method for
distinguishing TC from cortical axons. Our data support
the conclusion by Mrzljak et al. that ACh may suppress
activity in the parvocellular visual channel (which arrives
in layer 4cb).708 Neuron 56, 701–713, November 21, 2007 ª2007 Elsevier InNicotinic Gain Control in V1
Our physiology experiments show that nicotine enhances
visual gain in layer 4c in a manner that decreases contrast
threshold and increases overall responsiveness, and that
nicotine produces suppressive effects outside layer 4c.
A putatively presynaptic nicotinic mechanism that pro-
tects ascending input to cortex from cholinergic suppres-
sion has been shown previously in slice preparations of
rodent somatosensory (Gil et al., 1997), visual (Kimura
et al., 1999), auditory (Hsieh et al., 2000) and prefrontal
(Lambe et al., 2005) cortices. These studies demonstrate
that nicotine increases the amplitude of EPSPs arising
from stimulation of ascending pathways, but has no effect
on EPSPs in corticocortical pathways. What cannot be
determined from in vitro intracellular recordings is how
(or whether) this increased EPSP amplitude, demon-
strated for a brief train of electrical stimuli, will translate
into altered spiking responses to a sensory stimulus. Our
data thus represent a step forward in understanding the
effect of nicotinic modulation on sensory processing. We
show that activating nAChRs in layer 4c of V1 strengthens
the input from the visual world sufficiently to allow neurons
to reliably respond to low-contrast stimuli, which can
support better stimulus detection.
From layer 4c, these effects should propagate through-
out the visual cortex, because the major ascending visual
input in primates is via layer 4c. Furthermore, effects withinc.
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the receptive fields of multiple V1 neurons are summed. A
first step toward understanding the nature of that propaga-
tion would involve separate recording and iontophoresis
electrodes to allow activation of nicotinic receptors in layer
4c while recordings are made in other layers.
Nicotinic Suppression outside Layer 4c
The nicotinic suppression we demonstrate in layers 2, 3,
and 5 is also consistent with the anatomical data we
have presented. In the abovementioned in vitro slice stud-
ies, cholinergic suppression of corticocortical transmis-
sion was reported, but was shown to be a muscarinic
effect. The effect we observe is most likely due to activa-
tion of inhibitory neurons, as our anatomical data show
that very few principal cells in V1 express nAChRs.
Contribution of Low-Affinity nAChRs
While most cortical high-affinity nAChRs incorporate b2
subunits, there is also a population of a-bungarotoxin-
sensitive nAChRs in macaque V1. These receptors are
homomers of a7 nicotinic subunits and are interesting be-
cause they pass calcium ions with a high affinity (relative to
sodium ions). Receptor autoradiography has shown that
a7-nAChRs are present as a band in layer 4c of macaque
V1 (Han et al., 2003). It is not known whether they are
expressed on TC afferents or by intrinsic V1 neurons.
Unfortunately, available antibodies directed against the
a7 subunit did not pass our control experiments for use
in macaque. The extent to which a7-nAChRs contribute
to the effects we obtained using nicotine as an agonist
in V1 remains unresolved. They have a 5-fold lower affinity
for (and desensitize more rapidly to) nicotine, compared
with b2-nAChRs (in heterologous expression systems;
Fenster et al., 1997). However, this lower affinity may
mean that only a subset of a7-nAChRs is in a desensitized
state at any one time, and so these receptors may
have contributed—alongside the b2 subunit-containing
nAChRs—to the increased visual gain we observed. The
strong expression of a7-nAChRs in layer 4c, however,
reinforces the importance of this layer as a site for
nAChR-mediated cholinergic modulation.
Desensitization of Nicotinic Receptors
High-affinity nAChRs also desensitize to agonist exposure,
although variation in the extent to which native nAChRs de-
sensitize (including nondesensitizing responses) has been
reported (Dani et al., 2000; Lambe et al., 2005). It is interest-
ing that such a process is not apparent in our data. It is un-
likely that the enhancement we observed is itself a result of
desensitization; elevated spiking due to receptor desensiti-
zation would require the loss of a normally tonic inhibitory
effect. As nAChRs are cation channels, such tonic inhibition
would have to be mediated by inhibitory neurons. Our im-
munofluorescence data show that inhibitory neurons ex-
press nAChRs in all layers of V1, but enhancement was
seen only in layer 4c. That an effect specific to layer 4c (nic-
otinic enhancement) is the result of an anatomical featureNeualso specific to 4c (thalamic terminal expression of
nAChRs) is the more parsimonious explanation. Addition-
ally, recovery from desensitization to agonist exposure of
>1 min takes place over minutes (Reitstetter et al., 1999),
while the responses we observed recovered in under 45 s.
Natural Cholinergic Modulation
The nicotinic gain effects we demonstrate physiologically
arise from local agonist application on a background of
what may be unusually low basal ACh release (given the
anaesthetized state). Natural release in the awake animal
probably differs from iontophoretic application in two
regards: ACh is released continuously (Jimenez-Capdeville
and Dykes, 1996) and more broadly. The extent of cortical
neuropil covered by a single basal forebrain afferent in the
macaque is not known, but in the rodent each axon inner-
vates a region approximately 1–1.5 mm in diameter (Price
and Stern, 1983).
ACh will also activate both nAChRs and mAChRs.
nAChRs are ionotropic, so for a brief window (<200 ms)
after an increase in local ACh, nicotinic effects will proba-
bly dominate over the slower metabotropic effects medi-
ated by muscarinic receptors. In rodent somatosensory
cortex in vitro, the net effect of the nicotinic enhancement
at TC synapses and muscarinic suppression at cortico-
cortical synapses is that ACh leaves TC inputs relatively
enhanced on a background of suppressed intracortical
transmission (Gil et al., 1997).
In vivo, locally applied ACh has mixed effects on visual
responses in cat area 17 (Sato et al., 1987b; Sillito and
Kemp, 1983) and in marmoset and macaque V1 (Roberts
et al., 2005; Zinke et al., 2006). Previous studies do report
neurons that show an enhanced response with ACh, with,
interestingly, a larger proportion of neurons being en-
hanced in cat versus monkey. The only previous attempt
at pharmacological dissection of cholinergic effects in
visual cortex (Sato et al., 1987b) concluded that the facil-
itatory effects of ACh are mediated by mAChRs and
not nAChRs. However, this study was performed using
halothane anesthesia, which antagonizes nAChRs (Mori
et al., 2001), making interpretation of their results difficult.
It seems likely that natural ACh release would produce
a moremodest increase inspike rate than whatwehave ob-
served, due to the rapid and effective nature of acetylcho-
linesterase, the higher tonic ACh release in the awake ani-
mal (above which phasic release may represent a smaller
increment), and concurrent suppression via activation of
m2 AChRs on some thalamic afferents and on some synap-
ses between pyramidal neurons (Levy et al., 2006). Inter-
neurons in macaque V1 also strongly express mAChRs
(Disney et al., 2006), but whether the net effect of ACh act-
ing via mAChRs on inhibitory neurons will be an increase or
decrease in activity will depend on the effectors for the ac-
tivated G-proteins within each interneuron population.
ACh and Attention
In rodent, the cholinergic system is believed to be central
to the mechanisms underlying attention (Sarter et al.,ron 56, 701–713, November 21, 2007 ª2007 Elsevier Inc. 709
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our knowledge—not invoked as a candidate mechanism
for visual attention in primates, although similarities in the
effects of ACh and of visual attention have been noted by
another group working with V1 (Roberts et al., 2005;
Zinke et al., 2006). Generally, glutamatergic feedback
from higher visual areas, visuomotor areas, or both is
the preferred underlying model circuit for visual spatial
attention in the primate (Desimone and Duncan, 1995;
Reynolds and Chelazzi, 2004). Jack et al. (2006) extend
this model and conclude that while glutamatergic feed-
back probably underlies spatial attention, modulation
by ACh, norepinephrine, or both may play a role in sen-
sory gating.
Just how restricted the region of cortex influenced by
ACh can be will determine whether cholinergic effects
finally fall in a domain more properly called ‘‘arousal,’’ or
whether they will be found capable of subserving more
specific processes. At some point the distinction between
arousal and attention becomes difficult to operationally
define. Too little is currently known about the physiology
of the BFA or about the anatomy of the BFA projection
to cortex to resolve these questions.
Data often cited in favor of a glutamatergic mechanism
for attention is the finding that frontal eye field (FEF) stim-
ulation alters visual receptive field properties and im-
proves attentional performance in monkeys (Armstrong
et al., 2006; Moore and Fallah, 2004). Interestingly, the
FEF, in addition to projecting down through the visual
areas, also sends a direct projection to the BFA (Rus-
schen et al., 1985). It has also been shown in rodents
that activating glutamate receptors in the prefrontal cor-
tex causes ACh release in the posterior parietal cortex
(Nelson et al., 2005). Perhaps the FEF (and other frontal
and prefrontal areas) coactivates both glutamatergic
and cholinergic pathways leading back to the sensory
cortices, which act in concert to generate attentional
effects.
Overall, attentional effects on single units recorded in
visual cortex (McAdams and Reid, 2005; Reynolds et al.,
2000; Williford and Maunsell, 2006) and those induced
by nicotine in layer 4c are remarkably similar, although
the effects in the awake animal, particularly in V1, are far
more modest—which we would expect with endogenous
ACh release (see above subsection, ‘‘Natural Cholinergic
Modulation’’). Our data clearly demonstrate that ACh, act-
ing through nAChRs, serves to enhance the sensory drive
to early visual cortex in the macaque. Given the demon-
strated role for ACh in mechanisms of attention in rodents,
a role for cholinergic neuromodulation in models of spatial
attention in the visual system of the primate—subserved in
part by nicotinic gain control in layer 4c of V1—should be
considered and investigated further.
EXPERIMENTAL PROCEDURES
Brief methods are outlined below. For details see Supplementary
Methods.710 Neuron 56, 701–713, November 21, 2007 ª2007 Elsevier InAnimals
Adult male macaca fascicularis were used in these experiments. Pro-
cedures were approved by the Institutional Care and Use Committee
for NYU, in accordance with NIH guidelines.
Immuno-EM
Tracer Injection Surgery
Tracer injections were made in three anaesthetized animals. Three in-
jection tracks (three deposits/track; nine total) were made per animal,
at 8 mm antero-posterior (AP)/11 mm medio-lateral (ML) (with respect
to interaural zero), 9 mm AP/11 mm ML, and posterior to the central
sulcus at 11 mm ML. Following craniotomy and dural reflection,
0.25 ml deposits of 10% biotinylated dextran-amine (3000 MW, Bio-
Design) and 10% micro-ruby (BioDesign) in sterile saline were made
by Hamilton syringe at depths of 27, 26, and 25 mm below the pial
surface. The dura and bone plug were then replaced and ‘‘sealed’’ us-
ing agar. After 96 hr of unrelated physiological recording (Solomon
et al., 2004), a dose of 60 mg/kg pentobarbital was delivered, resulting
in a flat EEG.
Histological Preparation
Animals were exsanguinated and then transcardially perfused with
4 liters of 4% paraformaldehyde (PFA) with 0.25% glutaraldehyde
(GLA) in 0.1 M PB. V1 and the LGN were removed and post-fixed at
4C in 4% PFA. Within 48 hr, the blocks were sectioned at 40 mm
and reacted for 30 min in 1% sodium borohydride in PB. Every third
V1 section was set aside as a cytochrome-oxidase (CO) reference
for determining layers. CO histochemistry was commenced <72 hr
after perfusion, as described elsewhere (Disney et al., 2006).
‘Double DAB’ Procedure for Light Microscopic Identification
of Thalamic Injection Sites and V1 Terminal Fields
All LGN sections and every second V1 section were incubated in 1%
hydrogen peroxide in 0.01 M PBS for 30 min to block endogenous per-
oxidases. They were then placed into an avidin-HRP complex (Vectas-
tain Elite ABC Kit, Vector Laboratories) with 0.3% Triton x-100 over-
night at room temperature (RT). Sections were then reacted for
15 min using the ABC-DAB technique (Hsu et al., 1981). After rinsing,
the V1 set was placed into fresh avidin-HRP solution for 3 hr and
the ABC-DAB reaction was repeated. All sections were mounted and
dried overnight before a 10 min, on-slide exposure to 0.1% osmium
tetroxide in PB to enhance staining.
Single-Label Immunocytochemistry for EM
Using the above V1 ABC-DAB reference set, sequential sections with
labeled thalamic terminal fields were selected. A dimethylsulfoxide
‘‘freeze-thaw’’ technique (Wouterlood and Jorritsma-Byham, 1993)
was used to improve antibody penetration. After blocking endogenous
peroxidases (see preceding subsection), sections were incubated in
1% IgG-free bovine serum albumin (BSA, Molecular Probes) with
0.05% sodium azide (Sigma), 0.04% Triton x-100 (Triton) and 0.1%
Photoflo (Kodak) in PBS for 30 min.
Primary antibodies were diluted in PBS with 1% BSA and 0.05% so-
dium azide (Standard Blocking Solution). Added to this buffer were
a rabbit anti-b2 nicotinic subunit (45 mg/mL; BioDesign), a rabbit
anti-m1AChR (1:200; Chemicon) or a rat anti-m2AChR (1:250; Chem-
icon). Free-floating sections were incubated in one primary antibody
for 72 hr at RT.
Silver-intensified immunogold was used for visualization. After the
primary antibody incubation, sections were incubated overnight at
RT in a 0.8 nm gold-conjugated secondary antibody (goat anti-rabbit
IgG or goat anti-mouse IgG; Aurion), diluted 1:100 in Standard Block-
ing Solution. Sections were then post-fixed with 2% GLA in PBS for
10 min and, after brief washes in 0.2 M citrate buffer (pH 6.0) to remove
phosphate buffer salts, the gold particles were enhanced for 5 to
12 min using the Amersham IntenSE silver kit.
Following autometallography, sections were processed to visualize
the tract-tracer using the double DAB procedure described above,
omitting Triton x-100 in the overnight incubation. The now dually
labeled sections were fixed with 0.5% osmium tetroxide in PB forc.
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bation in 4% uranyl acetate in 70% ethanol at 4C. The next day the
dehydration series proceeded through 70%, 90%, and 100% ethanol
and three 30 min acetone rinses before overnight infiltration of 1:1
EMBED 812 (EM Sciences)/acetone and then 100% EMBED 812.
Following embedding and curing in EPON capsules, the tissue was re-
sectioned at 80–90 nm, mounted on formvar-coated nickel grids, and
counterstained with Reynold’s lead citrate before inspection under
a JEOL 1200 XL transmission electron microscope.
Data Collection
Using tissue maps drawn by camera lucida, data were collected from
thalamic terminal fields near the tissue/EPON interface. Images were
taken at 20,000–40,0003 magnification using either film or a Hama-
matsu CCD camera controlled by ATM software. Analysis was under-
taken offline.
Immunofluorescence
Tissue Preparation
Seven animals were perfused, and visual cortex was blocked, re-
moved, post-fixed, sectioned, and stored as described above, follow-
ing unrelated physiology experiments.
GABA/b2 Subunit Dual Immunofluorescence
Three animals were used for this experiment. Following freeze-
thawing, random sections were blocked in Standard Blocking Solution
and exposed to 2 antibodies in a single 72 hr, coincubation step at RT.
The polyclonal rabbit anti-b2 nicotinic subunit antibody (described
above) was combined with a monoclonal mouse anti-GABA (1:100;
Sigma).
Secondary antibodies were diluted 1:50 in Standard Blocking Solu-
tion. GABA-ir sites were visualized using Alexa 594 chicken anti-
mouse IgG (Molecular Probes) and nAChR-ir sites with Alexa 488
chicken anti-rabbit IgG (Molecular Probes). This incubation proceeded
in the dark, at RT, for 4–6 hr. Sections were then rinsed, mounted, cov-
erslipped, and stored in the dark at 4C.
Confocal Microscopy
Image montages from pia to white matter were taken of the opercular
surface of V1 (2–8 parafoveal visual field representation) using a Zeiss
LSM 310 confocal microscope. Counting was undertaken offline.
CBP/nAChR Dual Immunofluorescence
Four animals were used for this experiment. The protocol followed was
identical to that described for GABA/nAChR dual-labeling, with the
exception that 0.3% Triton x-100 (Triton) was added to the blocking
solution in place of the freeze-thaw process. CBPs were detected
using antibodies directed against PV (goat anti-PV 1:5000; Swant),
CB (mouse anti-CB D-28K 1:5000; Swant) and CR (goat anti-CR,
1:1000; Swant).
Physiological Recordings
Recordings of single or multiple units (generally <3 cells) were made in
anaesthetized (sufentanil citrate; 6–24 mg), paralyzed (vencuronium
bromide) macaques with a carbon fiber iontophoresis/physiology
electrode (Carbostar, Kation Scientific). The signal from the fiber was
amplified differentially (Dagan, Minnesota) with band-pass filtering
(300 Hz to 10 kHz) and digitized using an A/D board (SGI). Spikes
were discriminated and time-stamped by custom software running
on a Silicon Graphics computer. Spike waveforms were selected using
a discriminator window and stored for offline analysis.
Nicotine (0.25 M), sodium chloride (0.25 M), mecamylamine (0.1 M),
and Chicago Sky Blue 6B (2%), all dissolved in water, were delivered
via multibarrel pipettes (tip diameter 1–2 mm) connected to a Dagan
multichannel pump. Ten nano-Amp holding currents were used to
prevent leak.
After quantitative measures of orientation, spatial frequency, tempo-
ral frequency, and area tuning using drifting grating stimuli were made
(Xing et al., 2005), a drifting grating optimized for these parameters was
selected and contrast responses were measured in 12 logarithmic
steps from 2%–96% contrast, with or without ejection of drug solu-Netions. Drug ejection preceded visual stimulation by 10 s and never
exceeded 90 s without recovery (minimum 5 min). A baseline contrast
response was recorded before each ejection period and 2 or 3 ‘‘recov-
ery’’ contrast responses were recorded after drug application. This
series of recordings was repeated with varying ejection currents up
to a limit of 160 nA.
After physiological recording, animals were sacrificed and perfused,
and blocks of V1 were removed and sectioned. Laminar track recon-
struction was aided by CO histochemistry with Nissl counterstaining.
Parametric Analysis
For each condition (baseline, nicotine and/or mecamylamine at varying
ejection currents, recovery and controls), responses (R) were averaged
across 2–5 repeats of the sequence of stimulus contrasts (C). A Naka-
Rushton function,
R=Rmax
Cn
Cn +Cn50
+ sFR;
was fit to these data, and the parameters Rmax, c50, and n were
obtained, along with a parameter (sFR) capturing the offset attributable
to spontaneous firing.
The nicotine ejection current at which the maximal change in these
fit parameters was observed was determined and a parametric boot-
strap was performed by sampling randomly, with replacement,
from a Gaussian distribution defined by the mean and standard devi-
ation of the response to each contrast. Each set of sample responses
was fit with a Naka-Rushton function. One thousand iterations were
performed to obtain estimates of the parameter distributions. Statisti-
cal analyses of the difference between the nicotine condition and its
baseline were conducted for each fit parameter.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/56/4/701/DC1/.
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